Oct 29, 2025
The pharmaceutical industry is undergoing a paradigm shift, as Artificial Intelligence (AI) becomes a central force in transforming every stage of the drug lifecycle, from discovery to post-market performance. Among its most disruptive applications, AI in drug commercialization is redefining how therapies are...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
Newsletter/Whitepaper